Kaftrio for children with cystic fibrosis

Today the NHS confirmed that Kaftrio (or Tricafta in the US) will be available to prescribe in the UK for children (aged 12 years and older if they have the appropriate mutation) once it receives authorisation from the EMA. Further detail is here